Related by context. All words. (Click for frequent words.) 75 ribavirin RBV 74 pegylated interferon alpha 72 PegIFN RBV 72 relapsed MM 71 pegylated interferon alfa 71 ritonavir boosted 71 peginterferon alfa 2b 71 Peg IFN 71 FOLFOX6 71 peginterferon alpha 2a 71 alfa 2a 70 sustained virologic response 70 CIMZIA TM 70 evaluating tivozanib 70 Pegasys peginterferon alfa 2a 70 pegylated interferon alfa 2a 70 Pegasys ® 70 peginterferon alfa 2a 70 8mg/kg 70 pegylated interferon 70 peginterferon 70 LEXIVA r 70 achieved ACR# 70 oral ridaforolimus 69 viral kinetics 69 Aptivus ® 69 mg/m2 IV 69 ribavirin therapy 69 sustained virological response 69 peg interferon 69 oral rivaroxaban 69 #mg QD [002] 69 mg QD 69 plus ribavirin 69 administered subcutaneously 69 nab paclitaxel 69 mg q8h 69 ritonavir boosted atazanavir 69 docetaxel chemotherapy 69 undetectable HCV RNA 68 estramustine 68 R# #mg BID 68 mitoxantrone plus 68 ACTEMRA TM 68 #mg BID [001] 68 weekly intravenous infusions 68 tenofovir emtricitabine 68 Pegylated Interferon 68 COMBIVIR 68 lumiliximab 68 certolizumab 68 mg/m2 dose 68 3mg/kg 68 abacavir lamivudine 68 telaprevir dosed 68 virologic failure 68 interferon ribavirin 68 baminercept 68 pegylated interferon alpha 2a 68 Copegus ribavirin 68 naïve HCV 68 bendamustine 68 interferon alfa 2a 68 oral allopurinol 68 peg IFN 68 virologic response 68 antiretroviral naïve 67 SVR# 67 Taxotere ® 67 nitazoxanide 67 biochemical relapse 67 #mg/m# [001] 67 infliximab monotherapy 67 mg TID 67 COPEGUS 67 capecitabine Xeloda 67 azilsartan medoxomil 67 phase IIb study 67 atazanavir ritonavir 67 CHOP chemotherapy 67 CAELYX 67 HCV RESPOND 2 67 mcg BID 67 CLARITY study 67 doxorubicin docetaxel 67 HBeAg seroconversion 67 virological response 67 REYATAZ R 67 Peginterferon 67 weekly subcutaneous injections 67 #mg q8h 67 Xelox 67 BARACLUDE ® 67 DEB# 67 mg RDEA# 67 FOLFOX6 chemotherapy regimen 67 pegylated interferon peg IFN 67 alpha 2a 67 forodesine 67 chlorambucil 67 APTIVUS r 67 metastatic CRC 67 mg qd 67 5-FU/LV 67 plus prednisone 67 ibandronate 67 Pegasys R 67 APTIVUS 67 infusional 5-FU/LV 66 darunavir ritonavir 66 Doxil ® 66 PEG IFN 66 CIMZIA TM certolizumab pegol 66 VELCADE melphalan 66 cyclophosphamide doxorubicin vincristine 66 complete cytogenetic response 66 Lupuzor ™ 66 pyrazinamide 66 tipranavir 66 teriflunomide 66 lenalidomide Revlimid R 66 oral FTY# 66 PegIFN 66 omacetaxine mepesuccinate 66 TAXOTERE R 66 treatment naïve genotype 66 standard chemotherapy regimen 66 FOLFOX4 66 cyclophosphamide methotrexate 66 IFN alfa 66 ARB telmisartan 66 CIMZIA ™ 66 gemcitabine carboplatin 66 neratinib 66 achieved sustained virologic 66 anthracycline taxane 66 mg/m2 administered 66 virus HCV protease inhibitor 66 docetaxel Taxotere 66 μg dose 66 protease inhibitor PI 66 elotuzumab 66 doxorubicin cyclophosphamide 66 carboplatin paclitaxel 66 plus gemcitabine 66 recurrent glioblastoma multiforme 66 plus dexamethasone 66 Femara letrozole 66 Sandostatin LAR Depot 66 ara C 66 mcg kg 66 #.#g/day 66 mcg albinterferon alfa 2b 66 #mg/#mg 66 plus methotrexate 66 lopinavir r 66 daunorubicin 66 celgosivir 66 treatment naive genotype 66 HCV genotype 1 66 nucleotide analog 66 decitabine 66 mg BID 66 ELOXATIN 66 refractory CLL 66 peginterferon alfa 66 Pegylated interferon 66 adefovir 65 pegylated liposomal doxorubicin 65 metastatic colorectal carcinoma 65 cisplatin gemcitabine 65 #mg/m# [002] 65 PREZISTA r 65 dose cytarabine 65 dacarbazine 65 plus Copegus R 65 Phase #/#a 65 rapid virologic response 65 mg/m2/day 65 ug dose 65 mg ustekinumab 65 dosing cohorts 65 docetaxel Taxotere ® 65 trastuzumab Herceptin R 65 PEGINTRON TM 65 severe neutropenia 65 peginterferon alfa 2a #KD 65 FOLFIRI 65 GOUT 65 postmenopausal osteoporotic women 65 saline placebo 65 Allovectin 7 ® 65 Folfox 65 fluticasone salmeterol 65 TDF FTC 65 mcg doses 65 q8h 65 INCB# [001] 65 systemic ALCL 65 dose cohort 65 mg m² 65 Tarceva TM 65 oral levofloxacin 65 placebo dexamethasone 65 docetaxel Taxotere R 65 FOLFOX 65 Q#IR 65 subcutaneous enoxaparin 65 gemcitabine cisplatin 65 Hycamtin ® 65 relapsed refractory multiple myeloma 65 null responder HCV 65 metastatic renal cell carcinoma 65 interferon alfa 65 chronic HCV infection 65 octreotide LAR 65 detectable HCV RNA 65 4mg/kg 65 COPEGUS ribavirin 65 epoetin alpha 65 pegylated alpha interferon 65 maximally tolerated dose 65 custirsen 65 peginterferon ribavirin 65 piperacillin tazobactam 65 NSABP B 65 anthracycline containing 65 salmeterol fluticasone 65 galiximab 65 refractory chronic lymphocytic 64 budesonide foam 64 partial remissions 64 sargramostim 64 sorafenib Nexavar 64 #mg BID [003] 64 amoxicillin clavulanate 64 TMC# r 64 CANCIDAS 64 ARCOXIA 64 zidovudine lamivudine 64 PRT# 64 dose escalation phase 64 Xeloda ® 64 irinotecan chemotherapy 64 ixabepilone 64 receiving INTRON 64 budesonide pMDI 64 Fludara 64 FOLPI regimen 64 evaluating mipomersen 64 pomalidomide 64 null responders 64 chemoradiation therapy 64 5 FU leucovorin 64 assessing T DM1 64 ALT normalization 64 novel VDA molecule 64 Tesmilifene 64 metastatic hormone refractory 64 FTY# fingolimod 64 FUSILEV enhances 64 Ophena TM 64 HCV SPRINT 64 zoledronic acid Reclast 64 low dose cytarabine 64 SPRYCEL ® 64 efavirenz EFV 64 Allovectin 7 64 tinidazole 64 QVA# 64 Pemetrexed 64 sunitinib malate 64 relapsed myeloma 64 inhalations twice 64 AMEVIVE 64 chemoradiotherapy 64 paclitaxel Taxol ® 64 Lucentis monotherapy 64 oral methylnaltrexone 64 interferon alfa 2b 64 topotecan 64 biologic DMARD 64 Cimzia TM 64 APTIVUS R 64 VFEND 64 plus prednisone prednisolone 64 tirofiban 64 HuMax EGFr 64 alvespimycin 64 omega interferon 64 goserelin 64 recurrent genital herpes 64 intermittent dosing 64 Peginterferon alfa 2b 64 docetaxel 64 mycophenolate mofetil 64 melphalan prednisone 64 adriamycin 64 Quinamed 64 mg eq 64 telaprevir VX 64 sorafenib tablets 64 lenalidomide dexamethasone 64 steroid dexamethasone 64 unresectable stage 64 log# IU mL 64 active comparator 64 subcutaneously administered 64 Gemzar ® 64 FOLFIRI alone 64 pertuzumab 64 oxycodone CR 64 temsirolimus Torisel ® 64 QD dosing 64 REYATAZ r 64 Arikace 64 evaluable subjects 64 phase IIb trial 64 pegylated interferon alfa 2b 64 tipranavir r 64 alpha 2b 64 TMC# [001] 64 FluCAM 64 oxaliplatin Eloxatin 64 interferon gamma 1b 64 adalimumab Humira 64 gemcitabine chemotherapy 64 paclitaxel carboplatin 64 oral vancomycin 64 FROVA 64 lesinurad 64 metaglidasen 64 Myelodysplastic Syndrome MDS 64 #mg/day [002] 64 mCRC patients 64 ascending dose 64 uric acid lowering 64 cetuximab Erbitux ® 64 regorafenib 64 Phase 2a trial 64 aplindore 64 boosted protease inhibitor 64 comparator arm 64 LPV r 64 virological failure 64 amphotericin B 64 MCyR 64 oxymorphone ER 64 chronic HCV genotype 64 Jevtana 64 antiretroviral naive 64 telaprevir pegylated interferon 64 ritonavir boosted protease inhibitor 64 ceftazidime 64 MoxDuo IR 64 riociguat 63 microgram kg 63 5 Fluorouracil 63 iniparib 63 metastatic castration resistant 63 FOLFOX4 alone 63 sUA 63 intravitreal injection 63 CR nPR 63 resminostat 63 Aflibercept 63 relapsed multiple myeloma 63 DOXIL 63 Copegus 63 Omacetaxine 63 Alkeran 63 PEGASYS ® 63 corticosteroid dexamethasone 63 cEVR 63 pegIFN 63 TMC# C# 63 gemcitabine Gemzar ® 63 ISENTRESS 63 HBeAg negative patients 63 idraparinux 63 #mg QD [001] 63 monotherapy 63 antibody MAb 63 MIRCERA 63 hour bronchodilation 63 intravenous bisphosphonates 63 pegylated liposomal doxorubicin PLD 63 ATACAND 63 folinic acid 63 dexamethasone Decadron 63 HBeAg positive patients 63 reduce serum phosphate 63 methotrexate monotherapy 63 Torisel 63 idarubicin 63 desvenlafaxine succinate 63 darunavir r 63 ribavirin USP 63 Pharmacokinetics PK 63 remission induction 63 Peginterferon Alfa 2a 63 Velcade bortezomib 63 remission CR 63 anthracyclines taxanes 63 Actilon 63 neoadjuvant 63 metastatic renal cell 63 Natalizumab 63 PROSTVAC VF 63 Phase 1a clinical 63 viral kinetic 63 docetaxel prednisone 63 Ceplene/IL-2 63 MAGE A3 ASCI 63 refractory AML 63 PREZISTA rtv 63 Topotecan 63 plus COPEGUS 63 tolterodine ER 63 valopicitabine 63 Contrave# 63 relapsing MS 63 phase IIa 63 daily Infergen 63 Zometa hazard 63 CTAP# Capsules 63 5 fluorouracil leucovorin 63 BoNTA 63 dose cohorts 63 hepatitis C genotype 63 oral prodrug 63 glycoprotein IIb IIIa inhibitor 63 Darunavir 63 zalutumumab 63 Phase IIIb clinical 63 generation purine nucleoside 63 recurrent glioblastoma 63 oral deforolimus 63 dextromethorphan quinidine 63 ocrelizumab 63 dose dexamethasone 63 Engerix B 63 low dose ritonavir 63 PSMA ADC 63 metformin sulfonylurea 63 tenofovir Viread 63 canakinumab 63 prednisone prednisolone plus 63 TO AVOID PREGNANCY WHILE 63 Cloretazine 63 rilonacept 63 relapsed CLL 63 Taxotere R 63 posaconazole 63 adalimumab 63 BENICAR HCT 63 lintuzumab SGN 63 PEG interferon 63 ARCALYST ® 63 IXEMPRA 63 5mg/kg 63 BARACLUDE R 63 Sprycel dasatinib 63 nadolol 63 FOLPI 63 ARIKACE 63 RAPTIVA 63 q#d 63 cyclophosphamide chemotherapy 63 Campath alemtuzumab 63 undetectable virus HCV 63 ZOLINZA 63 tobramycin inhalation solution 63 undetectable HBV DNA 63 oblimersen 63 Viramidine 63 apremilast 63 mRCC 63 nucleoside analog 63 Virologic 63 Phase IIa trials 63 trastuzumab Herceptin ® 63 visilizumab 63 radezolid 63 vicriviroc 63 Q2W 63 Twinrix 63 advanced hepatocellular carcinoma 63 HCV Genotype 63 Naive Patients 63 highly emetogenic 63 CRp 63 Targretin capsules 63 paclitaxel chemotherapy 63 LANTUS R 63 somatostatin analog 63 dalteparin 62 fluorouracil 62 ongoing Phase 1b 62 aleglitazar 62 5FU 62 AGILECT R 62 stavudine d4T 62 efavirenz emtricitabine 62 inhaled corticosteroid ICS 62 paclitaxel Taxol 62 #.#mg/dL 62 pegfilgrastim 62 randomized #:#:# 62 bortezomib Velcade R 62 INFERGEN 62 #mg doses [002] 62 infusional 62 continuous intravenous infusion 62 naive HCV 62 chemotherapy cisplatin 62 pegylated interferons 62 imipenem 62 Bezielle 62 microgram mcg 62 ACR# response 62 paclitaxel Taxol R 62 CYT# potent vascular disrupting 62 adjuvant radiation 62 AVASTIN 62 Platinol ® cisplatin 62 velafermin 62 elacytarabine 62 phase IIb 62 RSD# oral 62 Phase #b/#a trial 62 lispro 62 liposomal amphotericin B 62 Telintra 62 patients coinfected 62 FASLODEX 62 raltegravir 62 azathioprine 62 gout flares 62 undetectable viral load 62 nucleotide analogue 62 Byetta exenatide 62 hormone refractory metastatic prostate 62 dose melphalan 62 elagolix 62 cytarabine daunorubicin 62 relapsing multiple sclerosis 62 carboplatin chemotherapy 62 cidofovir 62 Elitek 62 Panzem R NCD 62 plasma HCV RNA 62 saquinavir ritonavir 62 AZT zidovudine Retrovir 62 sitaxsentan 62 chemotherapy FOLFOX 62 Tarceva erlotinib 62 pemetrexed Alimta 62 Capecitabine 62 Amgen Neulasta ® 62 abacavir Ziagen 62 FOLFOX chemotherapy 62 temsirolimus 62 achieved CCyR 62 PegIntron 62 LymphoStat B TM 62 phase Ib 62 daily subcutaneous injections 62 brivaracetam 62 Chronic Hepatitis C 62 aspirin clopidogrel 62 dapagliflozin plus 62 patients evaluable 62 CR# vcMMAE 62 unfractionated heparin UFH 62 q#h 62 colesevelam HCl 62 de novo kidney transplant 62 Albuferon TM 62 KRAS mutations occur 62 TASKi3 62 PREZISTA ritonavir 62 Raptiva r 62 NATRECOR ® 62 #mg/day [001] 62 non splenectomized 62 TORISEL 62 GetGoal Phase III 62 aspirin heparin 62 intravenous immunoglobulin IVIg 62 lixisenatide 62 tocilizumab 62 Ribavirin 62 atazanavir sulfate 62 NVA# 62 sevelamer hydrochloride 62 ug kg 62 intradermal injections 62 Tasigna nilotinib 62 mg simvastatin 62 CCR5 tropic HIV 62 telaprevir dosing 62 LymphoStat B belimumab 62 fluoropyrimidine 62 ethambutol 62 ritonavir boosted lopinavir 62 TASKi2 62 #mg dose [002] 62 clodronate 62 Lantus ® 62 Laquinimod 62 MoxDuo TM IR 62 investigational oral hepatitis C 62 Durezol 62 Phase 1b clinical 62 CCyR 62 Flu Cy 62 Pharmacokinetic parameters 62 #mg ATC 62 HBeAg negative 62 Forodesine HCl 62 huN# DM1 62 REMINYL ® 62 TAXOTERE ® 62 RLY# 62 Roche Pegasys 62 azathioprine monotherapy 62 Betaferon R 62 concurrent chemoradiation 62 atazanavir Reyataz 62 GAMMAGARD 62 TTF Therapy 62 liposomal formulation 62 vincristine doxorubicin 62 Taxotere docetaxel 62 stage IIIb IV 62 Intravitreal 62 Ozarelix 62 PROMACTA 62 postoperative chemotherapy 62 Xeloda capecitabine 62 Irinotecan 62 TYKERB 62 SCH # 62 mitoxantrone 62 pegylated IFN 62 Tipranavir 62 MYDICAR ® 62 tiotropium 62 cabazitaxel 62 pazopanib 62 HBeAg + 62 Golimumab 62 Clevudine 62 mcg QD 62 intravenous bolus 62 REVLIMID ® 62 mcg dose 62 DermaVir Patch 62 Phase 1b trial 62 Mg Usa 62 EVIZON 62 3TC lamivudine Epivir 62 investigational protease inhibitor 62 IV bolus 62 rilpivirine 62 lanthanum carbonate 62 zolmitriptan 62 Herceptin trastuzumab 62 cetuximab Erbitux 62 virologic 62 mycophenolate mofetil MMF 62 blinded randomized placebo controlled 62 Infusion reactions 62 Phase Ib study 62 tipranavir ritonavir 62 erlotinib Tarceva ® 62 doripenem 62 rFSH 62 liposome injection 62 ULORIC 62 DU #b 62 dosing intervals 62 ascending doses 62 bepotastine besilate nasal spray 62 ACAPODENE 62 anakinra 62 mg kg dose 62 DexaSite 62 Kepivance 61 mometasone furoate 61 calcineurin inhibitor 61 Prograf ® 61 adjuvant tamoxifen 61 BRIM2 61 entecavir 61 undetectable hepatitis C 61 CLL SLL 61 rindopepimut 61 DAPT 61 febuxostat 61 virologic suppression 61 evaluable 61 beclomethasone dipropionate 61 amprenavir 61 deforolimus 61 genotypic resistance 61 dosing cohort 61 Darusentan 61 anagrelide 61 taxane chemotherapy 61 Glufosfamide 61 OncoVEX GM CSF 61 mapatumumab 61 definite stent thrombosis 61 nucleoside polymerase inhibitor 61 EmbraceAC 61 MabThera Rituxan 61 BENICAR 61 undetectable viral 61 Phase Ib II 61 neutropenic sepsis 61 TPV r 61 pioglitazone HCl 61 randomized multicenter trial 61 fostamatinib 61 metformin XR 61 Initiate Phase 61 briakinumab 61 dasatinib Sprycel ® 61 beta 1a 61 BEACOPP 61 serum urate 61 HBV DNA levels 61 Phase Ib clinical 61 zonisamide SR 61 palifermin 61 sunitinib 61 mg orally 61 Phase 1b 61 Combination therapy 61 sorafenib Nexavar ® 61 Boceprevir 61 protease inhibitors PIs 61 Elotuzumab 61 romidepsin 61 adefovir dipivoxil 61 Fludara ® 61 bicifadine 61 oral clodronate 61 CorVue ™ 61 sevelamer carbonate 61 divalproex sodium 61 Camptosar ® 61 orally administered inhibitor 61 crizotinib PF # 61 INTELENCE 61 ELACYT 61 #mg/kg [002] 61 nevirapine Viramune 61 inhaled iloprost 61 cyclophosphamide FC 61 mitoxantrone chemotherapy 61 Viread Emtriva 61 prednisone CHOP 61 multicentre randomized 61 Gleevec imatinib mesylate 61 RezularTM 61 cART 61 basal bolus regimen 61 insulin detemir 61 STELARA TM 61 Cimzia ® certolizumab pegol 61 catheter occlusion 61 Cladribine tablets 61 Epivir 61 AEGR 61 neoadjuvant treatment 61 acyclovir Lauriad R 61 DAS# CRP 61 low dose Iluvien 61 TELINTRA 61 subcutaneous SC 61 intravenous dosing 61 flutamide 61 multicenter randomized placebo controlled 61 TMC# [002] 61 injected subcutaneously 61 metastatic GIST 61 mCi kg 61 null responder 61 unresectable tumors 61 #mg ritonavir 61 trastuzumab Herceptin 61 EGFR expressing mCRC 61 hyperphenylalaninemia HPA due 61 Trastuzumab 61 CRLX# 61 phase IIb clinical 61 fosamprenavir 61 vidofludimus 61 multicenter placebo controlled 61 #μg [002] 61 doxorubicin HCl liposome injection 61 IDX# 61 intravenous iv 61 Valopicitabine 61 primary hypercholesterolemia 61 tazobactam 61 brand ciclesonide HFA 61 receiving VICTRELIS 61 cisplatin chemotherapy 61 #I TM# 61 YONDELIS 61 chronic HCV 61 subcutaneous injections 61 SSRI SNRI 61 oral diclofenac 61 alemtuzumab treated 61 Platinol ® 61 phase IIa clinical 61 IOP lowering 61 5 fluorouracil 61 HuMax CD4 61 TroVax ® 61 Multiple Ascending Dose 61 irbesartan 61 ribavirin Copegus 61 virologic response EVR 61 standard chemotherapy regimens 61 Pertuzumab 61 avosentan 61 subcutaneous doses 61 elvitegravir 61 EGFR TKI 61 satraplatin Phase 61 axitinib 61 lamivudine zidovudine 61 SAR# [004] 61 leukemia AML 61 Cimzia ® 61 alefacept 61 paliperidone ER 61 cilengitide 61 Free Survival PFS 61 PEG PAL 61 tanespimycin 61 NRTI backbone 61 VIRAMUNE XR 61 Acute Ischemic Stroke 61 HCV genotype 61 MIRAPEX 61 Factor Xa inhibitor 61 HyQ 61 neoadjuvant chemotherapy 61 recurrent GBM 61 Triapine R 61 oral chemotherapeutic agent 61 Pegylated Liposomal Doxorubicin 61 gemcitabine Gemzar 61 CERVARIX 61 mg p = 61 CombAT 61 yearly subcutaneous injections 61 Vfend 61 Chemophase 61 mg q#h 61 TransVax TM 61 Insulin PH# 61 Nexavar sorafenib 61 R sorafenib tablets 61 mucosal healing 61 #.#mg/kg [002] 61 Xanafide 61 lopinavir r arm 61 eltrombopag 61 antiviral efficacy 61 ZACTIMA 61 suppressive therapy 61 glatiramer acetate 61 Aloxi injection 61 previously untreated follicular 61 AAG geldanamycin analog 61 oral prednisone 61 EPIVIR 61 benazepril 61 Dual Opioid 61 lintuzumab 61 Traficet EN 61 Phase IIb trials 61 COPEGUS R 61 sevelamer 61 smoldering multiple myeloma 61 Pegintron 61 systemic corticosteroid 61 TBC# 61 humanized interleukin 6 61 timolol 61 epoetin beta 61 ABC/3TC 61 lopinavir 61 bosutinib 61 mesalamine granules 61 tacrolimus ointment 61 ® lenalidomide 61 DOXIL ® 61 cobicistat 61 dosed orally 61 ACR# responses 61 eosinophilic asthma 61 IIa trial 61 refractory NSCLC 61 sorafenib Nexavar R 61 IMiDs ® 60 abiraterone acetate 60 PEG SN# 60 dose titration 60 PASI scores 60 alkylating agent 60 tumor lysis syndrome 60 alemtuzumab Campath 60 metastatic malignant 60 CCR5 antagonist 60 unresectable HCC 60 IRX 2 60 Meets Primary Endpoint 60 chemotherapy gemcitabine 60 mcg Albuferon 60 thalidomide Thalomid 60 Dacogen injection 60 pharmacokinetic PK study 60 rituximab Rituxan ® 60 thymalfasin 60 IBS C 60 invasive candidiasis 60 #mg #mg #mg [003] 60 cinacalcet 60 xanthine oxidase inhibitor 60 recurrent metastatic 60 imiquimod cream 60 progression TTP 60 ILLUMINATE 60 danoprevir 60 phase 2a 60 midstage trials 60 mg/# hr 60 albiglutide 60 lamivudine 60 dose regimens 60 induce remission 60 LIALDA 60 SNT MC# 60 Gemcitabine 60 Capesaris 60 tolvaptan 60 vinorelbine 60 CRESTOR #mg 60 TNF antagonist 60 Phenoptin 60 R adefovir dipivoxil 60 corticosteroid dose 60 XELOX 60 caspofungin 60 resected pancreatic cancer 60 #mg dose [001] 60 plus OBT 60 XL# SAR# 60 μg kg 60 immune thrombocytopenic purpura ITP 60 NATRECOR R 60 aflibercept 60 REBETOL combination therapy 60 DCVax ® Brain 60 Lamictal XR 60 placebo controlled Phase III 60 antithymocyte globulin 60 metastatic malignant melanoma 60 Randomized Phase 60 By JENNIFER LEARN 60 Celsentri Selzentry 60 dose escalation clinical 60 Abrupt discontinuation 60 BCIRG 60 placebo controlled Phase 60 concomitant antibiotics 60 rabeprazole 60 LCP Tacro 60 VIAject ™ 60 GLIADEL R Wafer 60 odanacatib 60 rituximab Rituxan 60 inhibitor RG# 60 vismodegib 60 amrubicin 60 Phase #/#a trial 60 inhaled treprostinil 60 SUCCEED trial 60 glulisine 60 ER CHOP